PAK1 and neoplasm: In addition, we have also meticulously designed and synthesized a multitude of potent PAK1 inhibitors in the early stages, which have exhibited remarkable potential in the treatment of TNBC through their adept regulation of energy metabolism and the tumor microenvironment [25–27].